The China Pulse Oximeter Market was valued at $209 Million in 2025 and projected to reach to $387.5 Million by 2030, representing a compound annual growth rate of 9.2%. China's pulse oximeter market is positioned for sustained growth through 2030, driven by demographic shifts, healthcare modernization initiatives, and rising chronic disease prevalence.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
China's pulse oximeter market is valued at USD 209.0 million in 2025 and is projected to reach USD 387.5 million by 2030, representing an 85.5% increase over the forecast period.
China's rapidly aging demographic is a primary growth driver, with an increasing elderly population requiring continuous monitoring for chronic respiratory and cardiovascular conditions, boosting demand for pulse oximetry devices.
Significant government investments in healthcare infrastructure modernization across urban and rural regions are expanding access to diagnostic equipment, including pulse oximeters in hospitals, clinics, and home care settings.
China's expanding middle class is driving consumer awareness and adoption of personal health monitoring devices, with increasing preference for home-based pulse oximetry solutions for preventive healthcare management.
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | CONNECTED PULSE OXIMETERS (Technology) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 8.7% from 2025 to 2030 |
| Largest Segment | ADULTS (Age Group) |
| Market Size Base Year (Billions) | ~USD 3.92 (2025) |
| Revenue Forecast (Billions) | ~USD 5.95 (2030) |
| Segments Covered | Product, Type, Technology, Age Group, End User |
5 segment dimensions are covered across the global market.
| Segment | 2023 | 2024 | 2025 | 2029 | 2030 | 2031 | 2032 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|
| AMBULATORY CARE CENTERS | 15.7 | 16.5 | 17.9 | 24.4 | 26.4 | 28.4 | 30.7 | 8 |
| HOME CARE SETTINGS | 44.4 | 47.3 | 51.8 | 73.9 | 80.5 | 87.7 | 95.6 | 9.1 |
| HOSPITALS | 94.7 | 101.2 | 111.4 | 161.8 | 177 | 193.6 | 210.5 | 9.5 |
| OTHER END USERS | 9.5 | 10.1 | 11.1 | 16.1 | 17.6 | 19.3 | 21.1 | 9.6 |
| PRIMARY CENTERS | 5.3 | 5.5 | 5.9 | 7.9 | 8.4 | 9 | 9.7 | 7.2 |
| URGENT CARE CENTERS | 9.4 | 9.9 | 10.9 | 15.5 | 16.8 | 18.3 | 20 | 9 |
| TOTAL | 178.9 | 190.6 | 209 | 299.6 | 326.7 | 356.4 | 387.5 | 9.2 |
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| MEDTRONIC | Ireland | Public Company | Equipment (Bedside and multiparameter-integrated),Sensors (Reusable and disposable),Portable – Handheld, |
| MASIMO | United States | Private Company | Equipment – Bedside Monitors,Equipment – Portable (Handheld & Wearable),Equipment – Fingertip & Consumer, |
| NIHON KOHDEN CORPORATION | Japan | Public Company | Equipment – Bedside monitors with integrated SpO2,Equipment – Portable (handheld, wearable-capable, transport),Equipment – Fingertip/consumer-style oximeters, |
| KONINKLIJKE PHILIPS N.V. | Netherlands | Public Company | Equipment – Bedside monitors with integrated SpO2,Equipment – Portable (handheld and wearable clinical devices),Equipment – Fingertip/consumer-oriented devices, |
| ICU MEDICAL, INC. | United States | Public Company | Equipment – Bedside Pulse Oximeters and Multi-parameter Monitors,Sensors – Reusable and Disposable Oximetry Sensors,Portable – Handheld and Clinical Wearable Oximeters, |
| LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD. | China | Public Company | Equipment – Bedside / Multiparameter Monitors,Equipment – Portable Handheld,Wearable Pulse Oximeters, |
| GE HEALTHCARE | United States | Public Company | Equipment – Bedside and multi-parameter monitors with integrated SpO2,Sensors and disposables,Portable – Handheld and transport oximeters, |
| CONTEC MEDICAL SYSTEMS CO., LTD. | China | Public Company | Portable – Fingertip,Portable – Handheld,Portable – Wearable, |
| DRäGERWERK AG & CO. KGAA | Germany | Public Company | Equipment – Bedside Monitors (Conventional & Connected),Equipment – Portable (Handheld & Wearable),Equipment – Fingertip & Basic Portable, |
| OSI SYSTEMS, INC. | United States | Public Company | Equipment – Bedside Monitors,Equipment – Portable (Handheld/Wearable),Sensors and Disposables, |
| A&D COMPANY, LIMITED | Japan | Public Company | Equipment – Portable Handheld,Equipment – Portable Wearable,Equipment – Portable Fingertip, |
Medtronic is a publicly traded medical device company founded in 1949 and headquartered in Ireland, employing approximately 95,000 people globally.
Masimo is a private medical technology company established in 1989 in the United States with 2,200 employees specializing in patient monitoring solutions.
Nihon Kohden Corporation is a Japanese public company founded in 1951 that employs 6,116 people and operates in the medical device sector.
Koninklijke Philips N.V. is a large multinational public company founded in 1891 in the Netherlands with 63,670 employees operating across healthcare and technology sectors.
ICU Medical, Inc. is a publicly traded medical device company founded in 1984 in the United States with 13,000 employees.
Lepu Medical Technology is a publicly traded Chinese medical device company founded in 1999 in Beijing with 8,689 employees.
GE Healthcare is a publicly traded healthcare technology company founded in 2022 in the United States with 54,000 employees.
Contec Medical Systems is a publicly traded Chinese medical device company founded in 1996 with 1,712 employees.
Drägerwerk AG & Co. KGaA is a publicly traded German medical and safety technology company founded in 1889 with 16,033 employees.
OSI Systems, Inc. is a publicly traded technology company founded in 1987 in the United States with 7,337 employees.
A&D Company, Limited is a large publicly traded Japanese company founded in 1920 with 64,394 employees operating in measurement and medical device sectors.
China's pulse oximeter market is valued at USD 209.0 million in 2025 and is projected to reach USD 387.5 million by 2030.
China's pulse oximeter market is growing at a compound annual growth rate (CAGR) of 9.2% from 2025 to 2030.
Key drivers include China's aging population, rising prevalence of chronic respiratory and cardiovascular diseases, government healthcare infrastructure investments, and increasing adoption of home-use medical devices.
China's 9.2% CAGR outpaces the global average of 8.7%, indicating that China is a faster-growing market than the worldwide average.
China's market includes both international medical device manufacturers and domestic Chinese companies that leverage cost advantages and regulatory expertise to compete effectively.
This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, fundamental market dynamics, and key player strategies.
This research study used widespread secondary sources; directories, databases such as Dun & Bradstreet, Bloomberg BusinessWeek, and Factiva; white papers; annual reports; and companies’ house documents. Secondary research was used to identify and collect information for this extensive, technical, market-oriented, and commercial study of the global pulse oximeters market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.
In the primary research process, various supply & demand sources were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology and innovation directors, and related key executives from various key companies and organizations operating in the pulse oximeters market. The primary sources from the demand side include key executives from hospitals, physicians, clinicians, and research institutes.
A breakdown of the primary respondents is provided below:
Note 1: C-level primaries include CEOs, CFOs, COOs, and VPs.
Note 2: Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.
Note 3: Companies are classified into tiers based on their total revenue. As of 2024, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = < USD 1.00 billion.
To know about the assumptions considered for the study, download the pdf brochure
For the global market value, annual revenues were calculated based on the revenue mapping of major product manufacturers and OEMs active in the global pulse oximeter market. All the major product manufacturers were identified at the global and/or country/regional level. Revenue mapping for the respective business segments/sub-segments was made for the major players (who contribute at least 60-70% of the market share at the global level). Also, the global pulse oximeter market was split into various segments and sub-segments based on:

After arriving at the market size, the total pulse oximeters market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments & subsegments, data triangulation and market breakdown procedures were employed, wherever applicable.
A pulse oximeter is a non-invasive medical device used to measure the blood's oxygen saturation level (SpO2) and pulse rate. It typically works by emitting light through a body part—usually a fingertip or earlobe—and detecting the amount of oxygenated and deoxygenated hemoglobin based on light absorption.
Full forecast, segment splits, and company analysis for all Pulse Oximeter Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report